πŸ‡ΊπŸ‡Έ FDA
Patent

US 10202449

Cachexia treatment

granted A61KA61K2039/505A61K39/395

Quick answer

US patent 10202449 (Cachexia treatment) held by XBIOTECH INC. expires Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
XBIOTECH INC.
Grant date
Tue Feb 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K2039/505, A61K39/395, A61P, A61P21/06